Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative potential as a new type of cancer treatment that utilizes the immune system to fight the disease. It involves the process where genetically engineered T cells (patient/donor) express a chimeric antigen receptor to target a specific tumor antigen. Although a major groundbreaking invention in the field of cancer treatment, CAR-T Cell Therapy’s application is limited to treating patients with select liquid tumors only in the refractory and relapsed stage and these combine only for 5% of the total cancer patients today. There are necessary areas where research & development are still l...
